Mechanisms of Allergen-Specific Immunotherapy: T-Regulatory Cells and More

2006 ◽  
Vol 26 (2) ◽  
pp. 207-231 ◽  
Author(s):  
Johan Verhagen ◽  
Kurt Blaser ◽  
Cezmi A. Akdis ◽  
Mübeccel Akdis
2016 ◽  
Vol 65 (1) ◽  
Author(s):  
G. Ciprandi ◽  
G.L. Marseglia ◽  
M.A. Tosca

Specific immunotherapy (SIT) is the only treatment able to modify the natural history of the allergic subjects. Several aspects of the immunopathological response modified by SIT have been investigated; the first parameter historically studied was the production of allergen-specific antibodies. An increase of allergen-specific IgG4 and a decrease of IgE appear after SIT. A shift from Th2-polarized immune response toward Th1-oriented pattern has been reported after SIT. More recently, a crucial role for a subpopulation of T cells has been evidenced: T regulatory cells (Treg). Allergic patients have a defect of Tregs. SIT is able of inducing a specific Treg response. Sublingual immunotherapy is an alternative route of administration for SIT. Recent evidence shows that SLIT is also able of inducing a Treg response as detected by IL- 10 production.


2005 ◽  
Vol 24 (5-6) ◽  
pp. 533-548 ◽  
Author(s):  
Johan Verhagen ◽  
Alison Taylor ◽  
Kurt Blaser ◽  
Mübeccel Akdis ◽  
Cezmi A. Akdis

Immunotherapy ◽  
2012 ◽  
Vol 4 (4) ◽  
pp. 389-396 ◽  
Author(s):  
Michael B Soyka ◽  
David Holzmann ◽  
Cezmi A Akdis

Sign in / Sign up

Export Citation Format

Share Document